BioXcel Therapeutics, Inc.BioXcel Therapeutics, Inc.BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc.

No trades
See on Supercharts

Price target

5.000.000.00%
The 4 analysts offering 1 year price forecasts for BTAI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to BTAI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BTAI EPS for the last quarter is −0.32 USD despite the estimation of −0.51 USD. In the next quarter EPS is expected to reach −0.36 USD. Track more of BioXcel Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter BioXcel Therapeutics, Inc. revenue is expected to reach ‪966.92 K‬ USD. Check out BioXcel Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, BTAI price target is 5.00 USD with a max estimate of 7.00 USD and a min estimate of 1.00 USD. Check if this forecast comes true in a year, meanwhile watch BioXcel Therapeutics, Inc. stock price chart and keep track of the current situation with BTAI news and stock market news.